Researchers at Ludwig Maximilian University of Munich developed hybrid PLGA-PBAE nanoparticles that delivered mRNA vaccines ...

An LMU research team led by Professor Olivia M. Merkel, Chair of Drug Delivery at LMU, has developed a new delivery system ...

The study examined 180 patients with advanced lung cancer who received a COVID vaccine within 100 days before or after beginning immunotherapy, as well as 704 similar patients who did not. Vaccinated ...

The safety of mRNA vaccines, hailed as a saviour in the covid-19 pandemic, has been called into question by the US ...

This article explores how next-generation vaccines are expanding beyond infectious disease to target chronic conditions while ...

Moderna pivots to infectious disease & oncology, targeting cash break-even by 2028. Click here to see why I rate MRNA stock a ...

Research on mRNA vaccines have been under fire in the post-pandemic age, but these immunotherapies are showing promise in the ...

Opportunities in the mRNA quality monitoring market include the rising demand for QC due to the expansion of mRNA ...

Bayer's Monsanto sued COVID-19 vaccine makers Pfizer , BioNTech and Moderna in Delaware federal court on Tuesday for ...

The company submitted an application for a seasonal flu vaccine it believes to be a key growth driver in the years ahead.

Inside the 'silent epidemic' CEO says is 'bankrupting' the country Federal prosecutors indict 26 people for allegedly fixing college basketball games in widespread conspiracy DOJ: Ban on mailing ...

Researchers at Penn Medicine have developed an mRNA vaccine that could potentially cure allergies by stopping allergens from ...